Literature DB >> 12941924

Murine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages.

Daniel L Popkin1, Herbert W Virgin.   

Abstract

Despite robust host immune responses the betaherpesvirus murine cytomegalovirus (MCMV) is able to establish lifelong infection. This capacity is due at least in part to the virus utilizing multiple immune evasion mechanisms to blunt host responses. Macrophages are an important cell for MCMV infection, dissemination, and latency despite expression in the host of multiple cytokines, including tumor necrosis factor alpha (TNF-alpha), that can induce an antiviral state in macrophages or other cells. In this study, we found that MCMV infection of bone marrow-derived macrophages inhibited TNF-alpha-induced ICAM-1 surface expression and mRNA expression in infected cells via expression of immediate early and/or early viral genes. MCMV infection blocked TNF-alpha-induced nuclear translocation of NF-kappaB. This inhibition of TNF-alpha signaling was explained by a decrease in TNF receptor 1 (TNFR1) and TNFR2 that was due to decreased mRNA for the latter. These findings provide a mechanism by which MCMV can evade the effects of an important host cytokine in macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941924      PMCID: PMC224571          DOI: 10.1128/jvi.77.18.10125-10130.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Immune evasion by adenoviruses.

Authors:  J A Mahr; L R Gooding
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

2.  Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection.

Authors:  S C Henry; K Schmader; T T Brown; S E Miller; D N Howell; G G Daley; J D Hamilton
Journal:  J Virol Methods       Date:  2000-09       Impact factor: 2.014

3.  Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

Authors:  Laila E Gamadia; Ester B M Remmerswaal; Jan F Weel; Frederieke Bemelman; René A W van Lier; Ineke J M Ten Berge
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

4.  A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism.

Authors:  W Brune; C Ménard; J Heesemann; U H Koszinowski
Journal:  Science       Date:  2001-01-12       Impact factor: 47.728

5.  Tumor necrosis factor alpha-induced activation of downstream NF-kappaB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion. Involvement of PKCalpha, tyrosine kinase, and IKK2, but not MAPKs, pathway.

Authors:  C Chen; C Chou; Y Sun; W Huang
Journal:  Cell Signal       Date:  2001-08       Impact factor: 4.315

6.  The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients.

Authors:  I Nordøy; F Müller; K P Nordal; H Rollag; E Lien; P Aukrust; S S Froland
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

7.  Role of murine cytomegalovirus US22 gene family members in replication in macrophages.

Authors:  Carine Ménard; Markus Wagner; Zsolt Ruzsics; Karina Holak; Wolfram Brune; Ann E Campbell; Ulrich H Koszinowski
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 8.  Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion.

Authors:  Edward S Mocarski
Journal:  Trends Microbiol       Date:  2002-07       Impact factor: 17.079

9.  Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages.

Authors:  R M Presti; D L Popkin; M Connick; S Paetzold; H W Virgin
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

10.  Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.

Authors:  J Baillie; D A Sahlender; J H Sinclair
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  16 in total

Review 1.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

2.  Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein.

Authors:  Claudia Mack; Albert Sickmann; David Lembo; Wolfram Brune
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

3.  Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.

Authors:  Christian O Simon; Christof K Seckert; Doris Dreis; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins.

Authors:  Jillian A Bristol; Amanda R Robinson; Elizabeth A Barlow; Shannon C Kenney
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

5.  The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling.

Authors:  Vu Thuy Khanh Le; Mirko Trilling; Hartmut Hengel
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

Review 6.  Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection.

Authors:  Maja Mitrović; Jurica Arapović; Luka Traven; Astrid Krmpotić; Stipan Jonjić
Journal:  Med Microbiol Immunol       Date:  2012-09-11       Impact factor: 3.402

7.  Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1.

Authors:  Thomas E Morrison; Amy Mauser; Aloysius Klingelhutz; Shannon C Kenney
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1.

Authors:  Jason W Upton; William J Kaiser; Edward S Mocarski
Journal:  J Biol Chem       Date:  2008-04-28       Impact factor: 5.157

9.  Murine cytomegalovirus m38.5 protein inhibits Bax-mediated cell death.

Authors:  Igor Jurak; Uwe Schumacher; Hrvoje Simic; Sebastian Voigt; Wolfram Brune
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

10.  CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.

Authors:  Jillian A Bristol; Thomas E Morrison; Shannon C Kenney
Journal:  Mol Immunol       Date:  2009-06-11       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.